Synthesis, Molecular Docking Studies and Antifungal Activity Evaluation of New Thiazolyl-methylen-1,3,4-oxadiazolines as Potential Lanosterol 14α-demethylase Inhibitors

被引：0

作者：

Oniga, Smaranda ^{[1
]}

Araniciu, Catalin ^{[1
]}

Marc, Gabriel ^{[2
]}

Uncu, Livia ^{[3
,4
]}

Palage, Mariana ^{[1
]}

Oniga, Ovidiu ^{[2
]}

机构：

[1] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Dept Therapeut Chem, 12 Ion Creanga Str, Cluj Napoca 400010, Romania

[2] Iuliu Hatieganu Univ Med & Pharm, Fac Pharm, Dept Pharmaceut Chem, 41 Victor Babes Str, Cluj Napoca 400012, Romania

[3] Nicolae Testemitanu State Univ Med & Pharm, Fac Pharm, Pharmaceut Chem & Toxicol, Kishinev, Moldova

[4] Nicolae Testemitanu State Univ Med & Pharm, Sci Ctr Drug Res, Kishinev, Moldova

来源：

REVISTA DE CHIMIE | 2019年 / 70卷 / 10期

关键词：

Thiazolyl-methylen-1,3,4-oxadiazolines; Candida albicans; lanosterol; 14; alpha-demethylase; DERIVATIVES; DESIGN; RESISTANCE; AGENTS;

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Considering the well-established antifungal activity of azole compounds, a new series of thiazolyl-methylen-1,3,4-oxadiazolines derivatives were designed and synthesized as lanosterol-demethylase inhibitors. The final compounds were screened for antifungal activity against the Candida albicans ATCC 90028 strain. Molecular docking studies were performed to investigate the interaction modes between the compounds and the active site of lanosterol 14 alpha-demethylase, which is a target enzyme for anticandidal azoles. Theoretical ADME predictions were also calculated for the final compounds 5a-h.

引用

页码：3522 / 3526

页数：5

共 45 条

[41] Co(II), Ni(II), and Zn(II) complexes of 5-methyl-1,3,4-oxadiazol-2-amine Schiff base as potential heat shock protein 90 inhibitors: Spectroscopic, biological activity, density functional theory, and molecular docking studies
Al-Janabi, Ahmed S.
Al-Bayati, Ahmed F. K.
ALtaie, Omar Abdullah
Elzupir, Amin O.
Yousef, Tarek A.
APPLIED ORGANOMETALLIC CHEMISTRY, 2022, 36 (12)
[42] New S- and N- alkyl functionalized bis-1,2,4-Triazolyl-based derivatives as potential dual EGFRWT and EGFR T790M inhibitors: Synthesis , anti-proliferative evaluation, molecular docking study and ADMET studies
Ahmed, Abdelraheem M.
Aboelez, Moustafa O.
Ezelarab, Hend A. A.
Khodairy, Ahmed
Hassan, Abdelfattah
User, Marium Abo
Salah, Hanan
JOURNAL OF MOLECULAR STRUCTURE, 2025, 1324
[43] Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a] pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies
El-Wakil, Marwa H.
El-Dershaby, Hadeel A.
Ghazallah, Rasha A.
El-Yazbi, Amira F.
Abd El-Razik, Heba A.
Soliman, Farid S. G.
BIOORGANIC CHEMISTRY, 2024, 145
[44] New pyrazole-pyridazine hybrids as selective COX-2 inhibitors: design, synthesis, molecular docking, in silico studies and investigation of their anti-inflammatory potential by evaluation of TNF-α, IL-6, PGE-2 and NO in LPS-induced RAW264.7 macrophages
Osman, Eman O.
Khalil, Nadia A.
Magdy, Alaa
El-Dash, Yara
RSC MEDICINAL CHEMISTRY, 2024, 15 (08): : 2692 - 2708
[45] Synthesis of some New 9-Substituted 4-aryl-4,6-dihydropyrimido[5,4-c]quinoline-2,5(1H,3H)-diones as EGFR Inhibitors: In-vitro, Molecular Docking, Cytotoxic Evaluation, and ADMET Studies
Ramkaran
Kumar, Ankush
Bhatia, Rohit
Kumar, Ramesh
Rawal, Ravindra K.
Gupta, Praveen K.
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2023, 33 (01) : 33 - 41

← 1 2 3 4 5 →